Modulators of Corneal Wound Healing - Where Do We Stand?

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2024 Dec 2

PMID 39620664

Authors

Murugesan Vanathi

Affiliations

Soon will be listed here.

References

Qi H, Priyadarsini S, Nicholas S, Sarker-Nag A, Allegood J, Chalfant C . Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients. J Lipid Res. 2017; 58(4):636-648. PMC: 5392739. DOI: 10.1194/jlr.M067264. View

Yam G, Yang T, Geary M, Santra M, Funderburgh M, Rubin E . Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p - A robust cell selection tool for stem cell therapy of corneal scarring. J Adv Res. 2022; 45:141-155. PMC: 10006527. DOI: 10.1016/j.jare.2022.05.008. View

Sloniecka M, Danielson P . Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model. J Cell Mol Med. 2020; 24(8):4850-4862. PMC: 7176861. DOI: 10.1111/jcmm.15168. View

Qu M, Zhang X, Hu X, Dong M, Pan X, Bian J . BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring. Cell Death Discov. 2018; 4:5. PMC: 6060126. DOI: 10.1038/s41420-018-0066-1. View

Anumanthan G, Gupta S, Fink M, Hesemann N, Bowles D, McDaniel L . KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis. PLoS One. 2018; 13(3):e0192145. PMC: 5858751. DOI: 10.1371/journal.pone.0192145. View

Saika S, Miyamoto T, Yamanaka O, Kato T, Ohnishi Y, Flanders K . Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol. 2005; 166(5):1393-403. PMC: 1606394. DOI: 10.1016/s0002-9440(10)62357-7. View

Yang G, Roberts P, Gardner-Russell J, Shah M, Couper T, Zhu Z . From bench to clinic: Emerging therapies for corneal scarring. Pharmacol Ther. 2023; 242:108349. DOI: 10.1016/j.pharmthera.2023.108349. View

Fuchs A, Balne P, Giuliano E, Sinha N, Mohan R . Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo. PLoS One. 2022; 17(1):e0262046. PMC: 8746773. DOI: 10.1371/journal.pone.0262046. View

Yeung V, Zhang T, Yuan L, Parekh M, Cortinas J, Delavogia E . Extracellular Vesicles Secreted by Corneal Myofibroblasts Promote Corneal Epithelial Cell Migration. Int J Mol Sci. 2022; 23(6). PMC: 8951135. DOI: 10.3390/ijms23063136. View

10.

Sampaio L, Hilgert G, Shiju T, Santhiago M, Wilson S . Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury. Transl Vis Sci Technol. 2022; 11(7):9. PMC: 9287619. DOI: 10.1167/tvst.11.7.9. View

11.

Sampaio L, Hilgert G, Shiju T, Santhiago M, Wilson S . Corrigendum to "Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits" [Exp. Eye Res. 216 (2022) 108940]. Exp Eye Res. 2022; 224:109270. DOI: 10.1016/j.exer.2022.109270. View

12.

. Erratum: Publisher Correction: articles initially published in wrong volume. Cell Death Discov. 2019; 5:116. PMC: 6620268. DOI: 10.1038/s41420-019-0186-2. View

13.

Chowdhury S, Guha R, Trivedi R, Kompella U, Konar A, Hazra S . Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn. PLoS One. 2013; 8(8):e70528. PMC: 3734236. DOI: 10.1371/journal.pone.0070528. View

14.

Deng S, Dos Santos A, Gee S . Therapeutic Potential of Extracellular Vesicles for the Treatment of Corneal Injuries and Scars. Transl Vis Sci Technol. 2020; 9(12):1. PMC: 7645240. DOI: 10.1167/tvst.9.12.1. View

15.

McKay T, Hutcheon A, Zieske J, Ciolino J . Extracellular Vesicles Secreted by Corneal Epithelial Cells Promote Myofibroblast Differentiation. Cells. 2020; 9(5). PMC: 7290736. DOI: 10.3390/cells9051080. View

16.

Lim R, Tan A, Liu Y, Barathi V, Mohan R, Mehta J . ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis. Sci Rep. 2016; 6:20841. PMC: 4750002. DOI: 10.1038/srep20841. View

17.

Wilson S, Marino G, Torricelli A, Medeiros C . Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: A paradigm for fibrosis in other organs?. Matrix Biol. 2017; 64:17-26. PMC: 5705254. DOI: 10.1016/j.matbio.2017.06.003. View

18.

. Erratum in: Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury. Transl Vis Sci Technol. 2022; 11(10):30. PMC: 9587470. DOI: 10.1167/tvst.11.10.30. View

19.

Sampaio L, Hilgert G, Shiju T, Murillo S, Santhiago M, Wilson S . Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits. Exp Eye Res. 2022; 216:108940. DOI: 10.1016/j.exer.2022.108940. View

20.

Saccu G, Menchise V, Giordano C, Castelli D, Dastru W, Pellicano R . Regenerative Approaches and Future Trends for the Treatment of Corneal Burn Injuries. J Clin Med. 2021; 10(2). PMC: 7830803. DOI: 10.3390/jcm10020317. View